top of page

DISCLAIMER:
Brinter’s 3D bioprinted tissue implants are investigational devices that have not yet been approved for commercial use in any country. The described design properties and intended purpose are subject to further validation.

REGENERATIVEROTATOR CUFF 
IMPLANT
LAUNCHING 2027

Our bioinductive augmented implant for tissue reinforcement, BioMod™, supports healing, promotes tissue regeneration, and provides strength.

BioMod™ In Numbers:

3X

STRONGER VS SUTURE-ONLY REPAIR

26%

BETTER STRUCTURE FOR REGENERATION

68%

LESS FAILURES VS SUTURE-ONLY REPAIRS

3X

BETTER REGENERATIVE RESPONSE

Rotator_Cuff_Implant.png
Rotator Cuff_Lady_FINAL3.png

FLAGSHIP PRODUCT:
REGENERATIVE BREAST IMPLANT

Our flagship product is a regenerative breast reconstruction implant designed for post-mastectomy reconstruction and aesthetic revision applications.

Breast_lady2.png
Brinter Breast Implant

3D bioprinted implants designed to restore natural shape, softness, and tissue integration after mastectomy.

Additional Orthopedic Implants

ACL and Achilles implants are expected to follow the same accelerated pathway as the rotator cuff implant. The meniscus implant is expected to follow a longer De Novo/PMA pathway.

ACL_implant_lady.png

ACL Implant

implant_achielles.png

Achilles Implant

Meniscus_Woman.png

Meniscus Implant

Articular_Lady.png

Articular Cartilage

Implant R&D Pipeline

Nasap_implant_NO_BG.png

Nasal Implant

Genital_NO_BG.png

Genital Implants

Limp_flap_NO BG.png

Limb Implants

Spinal_Disc_implant_NO BG.png

Spinal Disc Implant

BRINTER, INC.

Santa Monica, California, USA (HQ)

Winston-Salem, North Carolina, USA

Turku, Finland (Subsidiary)

INVESTOR UPDATES

Sign up to receive investor updates.

© 2026 by Brinter, Inc.

    bottom of page